Dr. Adam Bradley Price, MD

Dr. Price practices at Yium, Shenouda & Miller Ptrshp in Chattanooga, Tennessee.

Dr. Price's NPI, 1922485770, was assigned on April 30, 2015. Dr. Price graduated from East Tennessee State University Quillen College of Medicine in 2015. Dr. Price holds Tennessee license 62618.

Dr. Price's primary practice is Yium, Shenouda & Miller Ptrshp, at 251 N Lyerly St, Chattanooga, TN 37404 in Hamilton County. The practice phone is (423) 826-8000.

Dr. Price's primary practice is Yium, Shenouda & Miller Ptrshp in Chattanooga, Tennessee. Dr. Price is also affiliated with Erlanger Baroness Hospital. The medical group on file is Nephrology Associates - Chattanooga. Dmand AI also links Dr. Price to 3 more hospitals, 2 dialysis centers and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Price practices, 7 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Price's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Price is licensed in Tennessee.

CMS data shows 11,233 Medicare services from Dr. Price across 44 procedure codes in 2024, for 955 Medicare patients. Medicare paid $333,077 for them.

CMS counts 955 Medicare patients who saw Dr. Price in 2024. The largest group is 75 to 84, with 392 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 14% are also on Medicaid. Their average risk score is 2.81, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Price's median patient age at 72, with 54% women.

In 2024, Dr. Price wrote 1,858 Medicare Part D claims for 384 patients. 92% of them were for generic drugs. CMS names the drug for 1,574 of them, across 30 drugs with 11 or more claims each, at $89,961 in total drug cost. In 2023, CMS named 1,235 claims across 28 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Price for performance year 2024, reported as part of a group. Dr. Price accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 173 general payments to Dr. Price from 23 drug and device companies from 2020 to 2025. Food and beverage make up the largest share, 92% of the total. AstraZeneca Pharmaceuticals LP paid the most, $934.

Dr. Price graduated from East Tennessee State University Quillen College of Medicine in 2015.